ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $211,000 | -72.5% | 6,391 | -61.7% | 0.03% | -51.5% |
| Q1 2022 | $767,000 | +127.6% | 16,684 | +228.0% | 0.07% | +153.8% |
| Q4 2021 | $337,000 | -69.3% | 5,087 | -71.0% | 0.03% | -67.1% |
| Q3 2021 | $1,096,000 | +49.5% | 17,554 | +98.3% | 0.08% | +64.6% |
| Q2 2021 | $733,000 | +218.7% | 8,854 | +65.7% | 0.05% | +220.0% |
| Q3 2020 | $230,000 | -83.8% | 5,344 | -94.9% | 0.02% | -72.2% |
| Q2 2018 | $1,421,000 | -57.1% | 104,500 | -77.3% | 0.05% | -51.8% |
| Q1 2018 | $3,312,000 | +168.4% | 459,400 | +37.1% | 0.11% | +211.1% |
| Q4 2017 | $1,234,000 | – | 335,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |